SGCIA
ACH

Smith Graham & Co Investment Advisors’s Accendra Health ACH Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$9.47M Sell
491,489
-2,917
-0.6% -$52.8K 1.09% 21
2023
Q3 		$7.99M Sell
494,406
-4,531
-0.9% -$80.4K 0.99% 24
2023
Q2 		$9.5M Sell
498,937
-21,524
-4% -$384K 1.15% 16
2023
Q1 		$7.57M Buy
520,461
+84,634
+19% +$1.52M 0.92% 33
2022
Q4 		$8.51M Buy
435,827
+70,951
+19% +$1.38M 1.04% 22
2022
Q3 		$8.79M Sell
364,876
-517
-0.1% -$15.9K 1.17% 15
2022
Q2 		$11.5M Sell
365,393
-20,307
-5% -$736K 1.42% 7
2022
Q1 		$17M Sell
385,700
-2,552
-0.7% -$110K 1.76% 1
2021
Q4 		$16.9M Sell
388,252
-50,912
-12% -$2M 1.68% 3
2021
Q3 		$13.7M Sell
439,164
-37,872
-8% -$1.49M 1.38% 11
2021
Q2 		$20.2M Sell
477,036
-106,997
-18% -$4.16M 1.78% 3
2021
Q1 		$22M Sell
584,033
-25,436
-4% -$795K 1.78% 5
2020
Q4 		$16.5M Sell
609,469
-10,909
-2% -$281K 1.52% 6
2020
Q3 		$15.6M Sell
620,378
-505,096
-45% -$7.37M 1.77% 1
2020
Q2 		$8.58M Buy
1,125,474
+56,198
+5% +$411K 1.04% 27
2020
Q1 		$9.78M Sell
1,069,276
-3,939
-0.4% -$23.8K 1.53% 4
2019
Q4 		$5.55M Sell
1,073,215
-28,030
-3% -$180K 0.54% 105
2019
Q3 		$6.4M Buy
1,101,245
+296,840
+37% +$1.33M 0.68% 71
2019
Q2 		$2.57M Sell
804,405
-1,970
-0.2% -$6.72K 0.28% 130
2019
Q1 		$3.31M Sell
806,375
-8,870
-1% -$56.1K 0.36% 130
2018
Q4 		$5.16M Buy
815,245
+21,870
+3% +$227K 0.63% 80
2018
Q3 		$13.1M Buy
793,375
+125,890
+19% +$2.14M 1.24% 8
2018
Q2 		$11.2M Buy
667,485
+67,753
+11% +$1.1M 1.05% 18
2018
Q1 		$9.33M Buy
599,732
+155,918
+35% +$2.78M 0.9% 31
2017
Q4 		$8.38M Buy
443,814
+148,552
+50% +$3.29M 0.79% 51
2017
Q3 		$8.62M Buy
+295,262
New +$8.72M 0.9% 34

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Smith Graham & Co Investment Advisors's ACH Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors reduced its Accendra Health (ACH) stake by 0.59% in Q4 2023, selling an estimated $52.8K and leaving 491,489 shares worth $9.47M. The position accounts for 1.09% of the portfolio, ranked #21.

Smith Graham & Co Investment Advisors first reported a position in ACH in Q3 2017 and has held it in 26 quarters since. The position peaked at $22M in Q1 2021. 227 funds tracked by Wall St. Rank hold ACH as of Q4 2023.

  • Smith Graham & Co Investment Advisors held 491,489 shares of Accendra Health worth $9.47M as of Q4 2023.
  • Smith Graham & Co Investment Advisors sold 2,917 Accendra Health shares in Q4 2023, an estimated $52.8K.
  • Accendra Health made up 1.09% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #21 holding.
  • Smith Graham & Co Investment Advisors first reported a position in Accendra Health in Q3 2017 and has held it in 26 quarters since.
  • Smith Graham & Co Investment Advisors's Accendra Health position peaked at $22M in Q1 2021.
  • 227 funds tracked by Wall St. Rank held Accendra Health as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.